A study has revealed that women with breast cancer are able to extend cancer survival by learning to relax. The study conducted in the U.S. examined the survival rates of women who had their cancer return after their initial treatment. The group of women volunteers worked with psychologists to come up with ways to reduce stress; stress being one of the main causes of cancer complications.
Reducing stress levels enabled the immune system to remain strong and resulted in Improvements in the quality of the women’s lives. The women who were part of the support group that helped them deal with stress lived on average 6 months longer than those that did not.
From Ohio State University, Columbus psychology professor Barbara Andersen said, “If you have someone who can provide effective, research-supported ways to reduce your stress, not only will that affect your mental health. It will likely affect your symptoms and your recovery.”
The 227 women who volunteered for the study were newly diagnosed with Stage II or III breast cancer. Some of the women received therapy to enable them to understand their stress, cope with it, stick to the cancer treatment prescribed to them and develop an over all better emotional state. The other women received a psychological assessment.
What was unusual about the results was that the therapy enhanced the women’s survival rates which had not been known before in other studies.
Andersen further explained the details of the study, saying: “It was far more than the popular notion of support groups of patients in a room talking about their troubles,” adding that “Certain patients talked about things that were stressful to them, but they also learned really effective ways to cope with that stress.”
Previous parts of the study showed that 45% of women who had attended the support group had less likelihood of their breast cancer returning after 11 years of follow ups.
The enhanced survival rates revealed in this last phase of the study were above and beyond any drug treatment improvements.
From Washington University in St. Louis, Sarah Gehlert stated that “An intervention that increased survival would be incredibly valuable. It represents a new tool for improving the lives of women with breast cancer.” She had no connection with the study.